4.8 Article

Discovery of a Viral NLR Homolog that Inhibits the Inflammasome

Journal

SCIENCE
Volume 331, Issue 6015, Pages 330-334

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1199478

Keywords

-

Funding

  1. NIH [DE018281, CA096500, AI057157, AI077437, CA156330, AI56324, AI91967, T32-AI007419, T32-AI007001, 5R21CA131645, F32-AI78735]
  2. American Heart Association [0640041N]
  3. Burroughs Wellcome Fund
  4. UNC
  5. Crohn's & Colitis Foundation of America

Ask authors/readers for more resources

The NLR (nucleotide binding and oligomerization, leucine-rich repeat) family of proteins senses microbial infections and activates the inflammasome, a multiprotein complex that promotes microbial clearance. Kaposi's sarcoma-associated herpesvirus (KSHV) is linked to several human malignancies. We found that KSHV Orf63 is a viral homolog of human NLRP1. Orf63 blocked NLRP1-dependent innate immune responses, including caspase-1 activation and processing of interleukins IL-1 beta and IL-18. KSHV Orf63 interacted with NLRP1, NLRP3, and NOD2. Inhibition of Orf63 expression resulted in increased expression of IL-1 beta during the KSHV life cycle. Furthermore, inhibition of NLRP1 was necessary for efficient reactivation and generation of progeny virus. The viral homolog subverts the function of cellular NLRs, which suggests that modulation of NLR-mediated innate immunity is important for the lifelong persistence of herpesviruses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available